2nd Advanced Practice Provider Hybrid Symposium

Presented by ibdhorizons

Hourly Schedule

Morning Session

8:15 - 9:00
Goals of Therapy in IBD: Where are we today?
10 Minute Presentation followed by a Panel Discussion with 2 other speakers.
Speakers:
Ghassan Wahbeh
9:00 - 9:45
Monitoring Disease Activity: Why & How
Speakers:
Karlee Ausk
9:45 - 10:15
Break
10:15 - 11:00
Family Planning, Pregnancy, and IBD Management
Speakers:
Sarah Chou
11:00 - 11:45
Novel and Promising Therapeutics in IBD
Speakers:
Scott D. Lee
11:45 - 12:30
Lunch
12:30 - 13:15
Infection Risk in IBD: Focus on COVID-19
Speakers:
Jeff Jacobs
13:15 - 14:00
Clinical Models of IBD Care: Eye on Telemedicine
Speakers:
Mitra Barahimi
14:00 - 14:45
Approach to the Symptomatic IBD Patient in Endoscopic
Speakers:
David Suskind
14:45 - 15:20
Skin Manifestations of IBD and IBD-therapy
Speakers:
Anita Afzali
Ghassan Wahbeh
Ghassan Wahbeh
MD, Director of the Inflammatory Bowel Disease Center at Seattle Children’s Hospital
Ghassan Wahbeh, MD, is the director of the Inflammatory Bowel Disease Center at Seattle Children’s Hospital. He is a Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine. Dr. Wahbeh’s clinical focus is in advanced care for children, adolescents, and young adults with Crohn’s Disease and Ulcerative Colitis, including advanced therapeutics and pre and post-surgery IBD management. Dr. Wahbeh’s research interests include advanced management of moderate and severe colitis in the outpatient and inpatient setting, managing complicated Crohn’s disease including fistulizing and stricturing phenotypes, mucosal healing in IBD, navigating surgical options in IBD and novel therapies.
 Dr. Wahbeh is actively involved as teaching faculty in medical student education, resident training, and fellow physician specialty training. He is the honored recipient of the Outstanding Teaching Faculty Award, as well as the Family Choice Award, and the Northwest Crohns & Colitis Foundation service award. He continues to serve as a member of the National Professional Education Committee and the Northwest Medical Advisory Committee of the Crohns and Colitis Foundation of America.
Karlee Ausk
Karlee Ausk
MD, Associate Director/Lead MD, Swedish IBD Center
Dr. Ausk attended medical school at the University of Washington, where she also completed Internal Medicine residency, chief residency, and fellowship in Gastroenterology and Hepatology. She practices general gastroenterology and hepatology with a particular interest in inflammatory bowel disease and colorectal cancer screening. She believes that healthcare providers have the privilege of accompanying patients and their families through the often stressful times brought on by an illness. She strives to guide patients in making healthcare decisions considering the best evidence available tailored to their individual story.
Sarah Chou
Sarah Chou
Physician Assistant
Sarah Chou is a Gastroenterology Physician Assistant and Teaching Associate at the University of Washington.
Scott D. Lee
Scott D. Lee
MD, Associate Professor of Medicine
Dr. Scott D. Lee is an associate professor of medicine with expertise in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Dr. Lee earned his bachelor’s degree at Pomona College and his M.D. at Jefferson Medical College. He completed his residency in internal medicine at the University of Colorado in Denver. After residency, Dr. Lee completed his gastroenterology fellowship at the University of Washington. After completing his fellowship, he attended the University of Chicago and Cedar-Sinai in Los Angeles as a visiting physician to gain additional training in IBD. Since finishing his fellowship, he has been an attending gastroenterology physician at the University of Washington Medical Center. Currently, his clinical practice is at the Digestive Disease Center at the University of Washington and is dedicated exclusively to providing care to patients with the diagnosis of IBD. His research is focused on inflammatory bowel diseases (IBD) including – new therapies for IBD, improving outcomes in the treatment and long-term management of IBD, evaluation of non-invasive biomarkers to assess disease activity in IBD patients, and the effects of the microbiome on IBD. He has participated in more than 100 clinical trials in IBD and continues to have an active clinical research program. He is a member of the Crohn’s Colitis Foundation of America (CCFA), American Gastroenterology Association, American College of Gastroenterology, and American Society of Gastrointestinal Endoscopy. He is a past chair of Northwest CCFA Chapter Medical Advisory Committee (CMAC) and continues as a current member of the CMAC.
Jeff Jacobs
Jeff Jacobs
MD, Gastroenterologist
Jeffrey Jacobs, MD, is a gastroenterologist and specializes in the care of patients with inflammatory bowel disease. Dr. Jacobs believes in a patient-centered and team based approach to medical care, while using the most up-to-date research to get the best outcome for his patients. He realizes that each patient is different, and a tailored approach is critical to the successful care of his patients. Dr. Jacobs' primary clinical interest is in the care of patients with inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Personal Interests: Dr. Jacobs enjoys playing with his dog at the park, trying out new cooking and baking recipes with his wife, traveling, reading books about history, and watching football (Go Hawks!).
Mitra Barahimi
Mitra Barahimi
Assistant Professor of Medicine
Dr. Barahimi is an assistant professor of medicine at the University of Washington with expertise in inflammatory bowel disease. She earned her bachelor’s degree and MD at the University of Washington. She went on to complete her residency in internal medicine and fellowship in gastroenterology at the University of Washington. In her clinical practice, she exclusively cares for patients with Crohn’s disease and ulcerative colitis. She is the principal investigator of IBD QORUS, a national quality improvement project that aims to improve the quality of care for patients with inflammatory bowel disease. She is also involved in clinical trials for new investigational therapies for inflammatory bowel disease. She is a member of the Crohn’s Colitis Foundation of America (CCFA), American Gastroenterology Association, American College of Gastroenterology and American Society of Gastrointestinal Endoscopy.
David Suskind
David Suskind
Director, Quality Improvement; Co-chair, Nutrition Subcommittee, Professor of Pediatrics
Anita Afzali
Anita Afzali
MD, MPH, Associate Professor of Clinical Medicine, Gastroenterologist, Medical Director of OSU IBD Center, Director of Operations for the Division of Gastroenterology, Hepatology and Nutrition
Dr. Anita Afzali is an Associate Professor of Clinical Medicine and a Gastroenterologist that specializes in Inflammatory Bowel Disease (IBD) at The Ohio State University Wexner Medical Center. She is the Director of Operations for the Division of Gastroenterology, Hepatology, and Nutrition, as well as the Medical Director of the OSU Inflammatory Bowel Disease Center. She holds the Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease. She received her medical degree and then completed an Internal Medicine residency and Gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology, and also graduated with a Master’s in Public Health. Her sub-specialty training includes a one-year advanced IBD fellowship at the University of Washington, prior to becoming faculty. While practicing at the University of Washington – Harborview Medical Center, Dr. Afzali served as the Director of the IBD Program and Associate Medical Director of Gastroenterology Clinics. Her research interests include clinical outcomes and association of bowel and joint disease, the influence of the metabolic syndrome and impact of race/ethnicity in IBD, as well as pharmacoeconomics, pediatric-to-adult transition, and women of childbearing age with IBD. She is also extensively involved in IBD clinical trials for investigational therapies. She has extensive peer-reviewed publications, an invited lecturer on national and international programs, and serves on several international advisory boards and committees including Co-Chair of the Crohn’s & Colitis National Professional Education Committee and Member of the ACG Minority Affairs and Cultural Diversity Committee.

Event Sponsors

We would like to extend a very special thank you to our sponsors for their support of our 6th Annual Pacific Northwest Symposium.

This event is endorsed by

Contact Us

Leave a Reply

Your email address will not be published. Required fields are marked *